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Abstract—Citric acid is found along with uranyl in the subsurface of former nuclear facilities because of its
use as a decontamination agent in the nuclear industry. Citrate’s metal chelating properties affect the mobility
of uranyl in the subsurface and consequently, citrate biodegradation may significantly impact uranyl fate and
transport. Under the non-growth conditions considered, low (micromolar) uranyl concentrations inhibit the
biodegradation of citrate by Pseudomonas fluorescens, a common subsurface denitrifying bacterium. Addi-
tionally, uranyl is found readily associated with the cell envelope of P. fluorescens. The observed inhibition
appears to be linked to the binding of uranyl to the cell surface and is reversible by desorbing cell-bound
uranyl. This study establishes a link between uranyl association with the cell surface and the observed
inhibitory effect of uranyl on cell metabolism. Copyright © 2003 Elsevier Ltd
1. INTRODUCTION
Uranium is a contaminant of concern in the subsurface
environment of a majority of former nuclear fuel and weapons
manufacturing facilities of the Department of Energy (DOE)
(Riley et al., 1992). In the 1950s and 1960s, wastes containing
a mixture of radionuclides and chelators such as citric acid,
oxalic acid, ethylenediaminetetraacetic acid (EDTA) or nitrilo-
triacetic acid (NTA) were disposed of in shallow trenches
(Department of Energy, 1997, 1998; Hartman et al., 2000). In
several cases, the radionuclides have reached the water table
and are threatening water supply wells or surface waters. The
chelators are not contaminants in their own right (with the
notable exception of NTA) but are important because they have
the potential to significantly alter uranyl mobility in the sub-
surface.
Specifically, citric acid is known to affect uranyl adsorption
to mineral surfaces. Citrate has been shown to enhance uranyl
adsorption on goethite and to reduce the adsorption of uranyl
on kaolinite (Redden et al., 1998). Thus, the mobility of uranyl
in the subsurface is crucially linked to the persistence of citric
acid and other chelators in the subsurface.
However, citric acid is readily metabolized by a variety of
microorganisms, both aerobically and anaerobically (Hugen-
holtz, 1993; Fuller and Scow, 1997; Coates et al., 1999). An
understanding of the propensity of citrate to be biodegraded in
the presence of uranyl would be useful in assessing its persis-
tence in uranyl-contaminated environments and thus its role in
uranyl fate and transport.
The goal of this study is to investigate the inhibitory effect of
uranyl on the biodegradation of citrate by Pseudomonas fluo-
rescens, a common subsurface denitrifier, at environmentally
relevant concentrations and under non-growth conditions. The
present study differs from others in several ways: (1) The
uranyl concentrations used are considerably lower than those in
other studies (10 mol/L vs. 400 mol/L). This is signif-
icant because measured uranyl concentrations in contaminated
aquifers at circumneutral pH rarely exceed 30 mol/L (Depart-
ment of Energy, 1997). Although DOE sites are heavily con-
taminated, uranyl sorbs strongly at circumneutral pHs and the
majority of uranyl is associated with the sediments at those
pHs. (2) Non-growth conditions were used and are representa-
tive of often oligotrophic subsurface environments. Previous
studies were conducted under growth conditions in the pres-
ence of ample supply of a carbon source. In this study, we
examine the metabolism of P. fluorescens under non-growth
conditions, in the presence of low, environmentally relevant,
uranyl and citrate concentrations. (3) Lastly, and most impor-
tantly, an additional novelty of this study resides in the fact that
it focuses on the relationship between uranyl biosorption and
the inhibition of citrate degradation by uranyl and establishes a
link between the two.
Several researchers have studied citrate degradation by bac-
teria in the presence of uranyl but exclusively under growth
conditions. Joshi-Tope and Francis (1995) and Francis et al.
(1992) showed that, in the presence of equimolar uranyl (0.52
mmol/L), there was no degradation of citrate by P. fluorescens.
However, in cell-free extract, citrate was fully biodegraded
under similar conditions. The authors concluded that the per-
sistence of citrate stemmed from the inability of the cells to
transport the uranyl-citrate complex across the cell membrane.
Another study by Banaszak et al. (1999) suggests that the
uranyl-citrate complex itself is toxic to P. fluorescens. Finally,
Huang et al. (1998) show that there is incomplete citrate (0.55
mmol/L) degradation by a mixed cell culture in the presence of
uranyl (0.42 mmol/L) at pH 6.
This study shows that uranyl inhibits cell metabolism at low,
environmentally relevant concentrations and that the inhibition
is associated with the binding of uranyl to the cell envelope.
This inhibitory effect is reversible by desorbing cell-bound
uranyl.
2. MATERIALS AND METHODS
2.1. Thermodynamic Calculations
Equilibrium speciation calculations were conducted using the chem-
ical equilibrium program HYDRAQL (Papelis et al., 1988). The ther-
modynamic data used are shown in Table 1. Briefly, the citrate com-
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plexation data were obtained from Lenhart et al. (2000) and Smith and
Martell (1997), the hydrolysis and carbonato complexes data from
Grenthe et al. (1992) except for the UO2(OH)20 complex taken from
Langmuir (1997).
2.2. Cell Growth Conditions
P. fluorescens is ubiquitous in the subsurface and has been used
previously for studies of the biodegradation of metal-citrate complex
(Francis et al., 1992; Joshi-Tope and Francis, 1995). P. fluorescens
ATCC 55241 biovar II was kindly provided by A. J. Francis
(Brookhaven National Laboratory, Upton, NY). Cells of P. fluorescens
were grown at 25°C in a sterile defined mineral salts medium dubbed
MM2 and amended with filter-sterilized (Nalgene 0.2-m PES syringe
filter, Nalge Co., Rochester, NY) citric acid (sodium citrate dihydrate,
Mallinckrodt, Phillipsburg, NJ) at a final concentration of 1 mmol/L.
One liter of MM2 contains 35.8 mg of NH4Cl, 2.75 mg of CaCl2 ·
2H2O, 6.25 mg of MgCl2 · 6H2O, 5.5 mg of KH2PO4, 2.585 mg
Fe(SO4)2NH4 · 12H2O, 1.155 mg of MnSO4 · H2O, 0.101 mg of CuCl2
· 2H2O, 0.095 mg of Na2MoO4 · 2H2O, 0.165 mg of ZnSO4 · 7H2O,
0.151 mg of CoCl2 · 6H2O, 2.13 g of MES (2-[N-morpholino]ethane-
sulfonic acid, Sigma Chemical Co., St. Louis, MO), 7.4 g of KCl
(Sigma) and was adjusted to pH 6.0  0.1. After 16 to 18 h (expo-
nential phase), the cells were harvested by centrifugation at 10,800g for
30 min at 25°C, washed twice with buffer BS1 and concentrated in BS1
(1 L of cells to 100 mL). BS1 consists of 0.1 mol/L KCl (7.4 g/L) and
102 mol/L MES (2.13 g/L) at pH 6.0  0.1. This cell concentrate was
used for all experiments.
2.3. Citrate and Glucose Degradation
Degradation experiments were conducted in 500-mL polycarbonate
(PC) bottles containing 50 mL of sterile BS1. An adequate volume of
filter-sterilized 1 mmol/L uranyl solution (uranyl nitrate, Johnson Mat-
they, Ward Hill, MA) and 1 mmol/L filter-sterilized citrate or 10
mmol/L filter-sterilized glucose (D-[]-glucose anhydrous, Sigma
Chemical Co., St. Louis, MO) solution were added to the bottles. In
addition, 10 L (0.1 Ci) of filter-sterilized [1,5]14C-citrate (DuPont,
DE) or 10 L (0.1 Ci) uniformally labelled 14C-glucose (ICN Phar-
maceuticals, Irvine, CA) were added to each bottle. Each bottle was
prepared in triplicates. The addition of 14C labeled citrate or glucose
changes the total concentration by  1%.
After 30 min, cells were added to each bottle to yield a final OD600
of 0.1 (5 mg protein/L1 or 1.4 1011 cells/L1). The capped bottles
were incubated at 25°C on an orbital shaker at 100 rpm, in the dark. pH
remained within 0.1 unit of pH 6.0 in all cases. During the degradation
experiment, samples were collected aseptically from the bottles, filtered
through a 0.22-m GVHP filter (Millipore Corporation, Bedford, MA)
and the concentration of uranyl and citrate determined. To quantify
uranyl, the filtrate was diluted five-fold with nitric acid (final HNO3
concentration 0.2%; Optima grade, Fisher Scientific, Pittsburgh, PA)
and analyzed on an HP 4500 series Inductively Coupled Plasma-Mass
Spectrometer (ICP-MS). To quantify 14C-citrate, 1 mL of the filtrate, 1
mL of MilliQ water and 20 L of concentrated hydrochloric acid
(A.C.S. Plus grade, Fisher Scientific, Fair Lawn, NJ) were mixed in a
20-mL scintillation vial and purged with nitrogen gas for 20 min to
remove CO2. The vial was analyzed on a TriCarb 2500 TR/AB Packard
Liquid Scintillation Analyzer with 5 mL of Ultima Gold XR liquid
scintillation solution (Packard, Meriden, CT). Cell lysis was monitored
by collecting samples, centrifuging them (at 16,000g for 30 min) and
analyzing the supernatant for protein by the colorimetric Bradford
method (Biorad Laboratories, Hercules, CA). There was no interfer-
ence from citrate or uranyl and the method was sensitive enough to
detect cell lysis (as defined by passage through a French Pressure Cell
(SLM Aminco) at 1000 psi once). For heat-killed cells, the cell con-
centrate was subjected to 60°C for 1 h before the addition to each
bottle. The heat treatment was sufficient to halt citrate degradation. The
integrity of the cells was verified by the protein assay described above.
Control experiments were conducted ([citrate]  1 mol/L, [uranyl]
 0, 3 or 5 mol/L) to verify the complete biodegradation of citrate to
CO2. The experiments were identical to the ones described above with
the difference that a scintillation vial containing 1 mL of 1N NaOH was
suspended in the headspace of the PC bottle using Teflon tape. As
14C-citrate was being metabolized, the 14C-CO2 evolved and was
captured in the base trap. The bottles were destructively sampled after
25 h. Measuring 14C-CO2 in the base trap produced identical results to
measuring 14C remaining in solution. Thus, it was concluded that
citrate was fully biodegraded to CO2 and the latter experimental design
was adopted for the remainder of the study.
Table 1. Thermodynamic constants used in calculation of chemical speciation. The values shown are formation constants adjusted to an ionic
strength of 0.
Species logK Reference
4 UO22  7 H2O  (UO2)4(OH)7–  7H –21.9 Grenthe et al. (1992)
2 UO22  3 H2O  CO32–  (UO2)2(OH)3 · CO3–  3H 1.01 Grenthe et al. (1992)
UO22  3 CO32–  UO2(CO3)34– 21.6 Grenthe et al. (1992)
UO22  2 CO32–  UO2(CO3)22– 16.94 Grenthe et al. (1992)
UO22  CO32–  UO2CO30 9.72 Grenthe et al. (1992)
UO22  CO32–  UO2CO3(s) 14.4 Smith et al. (1997)
UO22  2 H2O  UO2(OH)2(s)  2H –4.93 Grenthe et al. (1992)
H  Cit3–  H3Cit 14.285 Smith et al. (1997)
2 H  Cit3–  H2Cit– 11.157 Smith et al. (1997)
H  Cit3–  HCit2– 6.396 Smith et al. (1997)
3 UO22  7 H2O  (UO2)3(OH)–  7H –31 Grenthe et al. (1992)
2 H  CO32–  H2CO3 16.681 Smith et al. (1997)
H  CO32–  HCO3– 10.329 Smith et al. (1997)
2 UO22  2 Cit3–  (UO2)2Cit22– 20.8 Smith et al. (1997)
UO22  Cl–  UO2Cl 0.21 Smith et al. (1997)
UO22  Cit3–  UO2Cit– 8.00 Lenhart et al. (2000)
3 UO22  4 H2O  (UO2)3(OH)42  4H –33 Grenthe et al. (1992)
3 UO22  5 H2O  (UO2)3(OH)5  5 H –15.5 Grenthe et al. (1992)
3 UO22  4 H2O  (UO2)3(OH)42  4H –11.9 Grenthe et al. (1992)
2 UO22  2 H2O  (UO2)2(OH)22  2H –5.62 Grenthe et al. (1992)
UO22  2 H2O  UO2(OH)20  2H –12.0 Langmuir (1997)
2 UO22  H2O  (UO2)2OH3  H –2.7 Grenthe et al. (1992)
UO22  3 H2O  UO2(OH)3–  3H –19.2 Grenthe et al. (1992)
UO22  H2O  UO2OH  H –5.2 Grenthe et al. (1992)
K  Cit3–  KCit2– 1.22 Smith et al. (1997)
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2.4. Uranyl Association With Cells
The samples intended for uranium analysis were filtered with GVHP
filters selected specifically for their low uranyl binding capacity (3%
for 1 mol/L uranyl at pH 6.0). To determine the localization of uranyl
within the cells, we followed the standard method of cell fractionation.
Briefly, cells were lysed using a French Press, the lysate (mixture of
lysed and intact cells) centrifuged to remove intact cells and large
membrane fragments. The supernatant was then ultracentrifuged to
separate the cytoplasmic and membrane fractions. A more detailed
protocol follows: Bottles were prepared as described above but without
14C-citrate and with 3 mol/L uranyl, incubated in the dark for 23 to
24 h and centrifuged for 30 min at 10,800g. The supernatant was
removed and the pellet resuspended in 3 mL of fresh sterile BS1. The
resulting cell concentrate was lysed by three passages through a French
Pressure Cell at 1000 psi. The suspension was analyzed for total protein
and total uranyl. The lysate was placed in two Eppendorf microcentri-
fuge tubes (dubbed A and B) and centrifuged at 10,800g for 30 min.
The supernatants (containing the intracellular fraction and membrane
fractions) were analyzed for protein (A) and uranyl (B) respectively.
The pellets (containing unbroken cells and a portion of the membrane
fraction), were resuspended in 0.5 mL of concentrated HNO3 (A used
for U analysis) or in 0.5 mL of MilliQ water (B used for protein
measurement). Analysis of total protein before centrifugation and pro-
tein in the supernatant and in the pellet allowed the calculation of the
efficiency of cell lysis. The supernatant (combined from A and B) was
transferred to a polycarbonate ultracentrifuge tube and centrifuged at
208,000g for 2 h at 4°C. The supernatant from ultracentrifugation
represents the cytoplasmic fraction and was analyzed for uranium. The
pellet (membrane fraction) was resuspended in 1 mL of concentrated
HNO3 and measured for U.
2.5. Viability
To determine the effect of uranyl on cell viability, bottles were
prepared as described above and sampled periodically. The samples
were diluted 104- to 105-fold with sterile BS1 and 100 L of the dilute
solution plated onto tryptone glucose extract agar (Difco Laboratories,
Detroit, MI) in triplicates. The plates were incubated at 30°C for 24 h
and the colonies counted manually.
2.6. Reversibility of Inhibition
Bottles containing sterile BS1 (50 mL), 10 mol/L citrate (with 10
nmol/L of 14C tracer), 20 mol/L uranyl and cells at a final OD600 of
0.3 were incubated in the dark for 4 h and centrifuged at 10,800g for 30
min. The supernatant was analyzed for U. The cells were resuspended
in 50 mL of 0.1 mol/L of KHCO3 and incubated in the dark for 1 h. The
bottles were then centrifuged and the supernatant analyzed for uranyl
and discarded. It was replaced by 50 mL of BS1 containing 10 mol/L
of citrate spiked with 14C-citrate and citrate degradation was measured
over time. At the end of the experiment, the bottles were centrifuged,
the pellets dissolved in 1 mL of concentrated HNO3 and analyzed for
uranyl.
2.7. Electron Microscopy
Suspensions of freshly grown cells (final OD600 of 0.26 or 0.13)
containing 10, 40 or 100 mol/L uranyl and 1 mol/L citrate were
incubated in the dark for 24 h. The cells were pelleted (at 10,800g for
30 min), fixed in 2% glutaraldehyde (EM grade Polysciences Inc., PA),
dehydrated in an ethanol gradient series (70, 80, 90 and 100% ethanol)
and embedded in Spurr low viscosity resin (Polysciences Inc., PA).
Subsequently, the polymerized resin was thin-sectioned using a
Reichert Ultracut S microtome and imaged with a Philips Transmission
Electron Microscope TEM300 (equiped with Gatan, Bioscan CCD
camera) at 80 kV using a 20-m aperture. The Energy Dispersive
X-ray spectra were collected with an EDAX DX-4.
2.8. Spectrophotometry
To determine whether cells outcompete citrate for uranyl in BS1, the
absorbance spectrum of the uranyl-citrate complex was monitored
before and after the addition of heat-killed cells. The uranyl-citrate
complex absorbs at 437 nm (Dodge and Francis, 1997) and the uranyl
cation at 420 nm. Citrate does not absorb in the 400 to 500 nm range.
Uranyl and citrate (each 100 mol/L) were placed in BS1 buffer and a
spectrum collected in the range 400 to 500 nm on a Perkin Elmer
Lambda Bio spectrometer in a 10-cm path length cell. Heat killed cells
(OD600 0.2 or 0.5) were added and after a short equilibration (2 or 5
min), a sample was filtered and a spectrum collected.
3. RESULTS
3.1. Fate of Uranyl
Numerous uranyl-citrate complexes have been proposed in
the literature: a 1:1 uranyl-citrate complex (Newman et al.,
1951; Rajan and Martell, 1965; Markovits et al., 1972; Nunes
and Gil, 1987; Lenhart et al., 2000), a 2:1 complex (Nunes and
Gil, 1987), a 2:2 complex (Newman et al., 1951; Feldman et al.,
1954; Rajan and Martell, 1965; Markovits et al., 1972; Nunes
and Gil, 1987; Allen et al., 1996), a 2:3 complex (Dodge and
Francis, 1997), a 3:2 complex (Feldman et al., 1954) and a
hexameric complex (Rajan and Martell, 1965). In our specia-
tion calculations, we consider only the complexes for which a
formation constant exists: the mononuclear (1:1) and binuclear
(2:2) complexes. Thermodynamic calculations indicate that at
the micromolar concentrations used in our experiments, the
mononuclear complex dominates (Table 2). A complete list of
Table 2. Calculated speciation of uranyl and citrate in solutions with 1 mol/L uranyl and 1 mol/L citrate, 3 mol/L uranyl and 1mol/L citrate
or 1 mol/L uranyl and 10 mol/L glucose at pH 6.0 and atmospheric PCO2. Free citrate refers to protonated and deprotonated citrate. UO22 refers
to uranyl in the free ion form, UO22 hydroxides and UO22 carbonates refer to the sum of all uranyl hydroxide solution complexes and all solution
uranyl carbonate species respectively. Carbonate complexes do not become important until pH  6.0.
Species
1 mol/L citrate and 1 mol/L uranyl 1 mol/L citrate and 3 mol/L uranyl
10 mol glucose
and 1mol
uranyl
Percent uranyl as Percent citrate as Percent uranyl as Percent citrate as Percent uranyl as
UO2Cit– 22 22 12 37
(UO2)2(Cit)22– 1 1 1 3
Free citrate 63 50
KCit2– 14 14
UO22 11 8 14
UO22 hydroxides 50 59 65
UO22 carbonates 15 19 21
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the thermodynamic data used in the speciation calculations is
given in Table 1.
The empirical determination of a formation constant for the
mononuclear U:cit complex by three independent research
groups resulted in three different values:
log 1,1  7.4, 6.7 and 6.3 at I  0.1 (respectively Rajan and
Martell, 1965; Lenhart et al., 2000; and Markovits et al., 1972).
Lenhart et al. (2000) studied the formation of the mononuclear
uranyl:citrate complex in NaClO4 at I  0.1 at UT  1
mol/L and [citrate]T  20 mol/L to 0.6 mmol/L at pH 4.0
and 5.0. The experimental conditions in our study were similar
with UT  1 to 5 mol/L, [citrate]T  1 mol/L and pH 6.0.
In contrast, the complexation constants determined by Rajan
and Martell (1965) were obtained at considerably higher uranyl
and citrate concentrations 0.68 to 17 mmol/L at the same I 
0.1 Markovits et al. (1972) obtained their constants at I  1.0
and U and citrate concentrations  30 mol/L to 1.2 mmol/L.
Therefore, we used the complexation constant determined un-
der experimental conditions most akin to ours (Lenhart et al.,
2000) as is reflected in Table 1.
The thermodynamic calculations predict that 100% of the
uranyl present is in solution (Table 2). This prediction is
confirmed by experimental data collected in the absence of
cells and showing 100% uranyl in solution over the time
frame of our experiments (Fig. 1). However, in the presence of
cells,  10% of uranyl is measured in solution (Fig. 1). These
data suggest a strong association of uranyl with cells. The
association of uranyl with cells is likely to be due to sorption of
uranyl to cells rather than intracellular uptake of uranyl because
heat-killed cells scavenge uranyl as effectively as metabolically
active cells (Fig. 1).
Thermodynamic calculations predict that 22% of citrate will
be bound in a uranyl-citrate complex (Table 2) for [U]  [cit]
 1 mol/L. However, due to the uncertainty in the thermo-
dynamic data, it is not possible to state with certainty what
fraction of the 90% uranyl scavenged by cells (Fig. 1) was
initially bound with citrate. Also, the uranyl and citrate con-
centrations are too low to directly measure the initial presence
of the uranyl-citrate complex. At higher uranyl and citrate
concentrations, at which it is possible to monitor the uranyl-
citrate complex(es) by spectrophotometry (Fig. 2), the dissoci-
ation of the uranyl-citrate complex in the presence of cells is
clearly observed. The uranyl-citrate complex has a character-
istic absorption spectrum with a peak at 437 nm (Dodge and
Francis, 1997). The peak appears immediately upon mixing
100 mol/L uranyl and 100 mol/L citrate in a 0.1 mol/L KCl
solution buffered at pH 6.0 with 10 mmol/L MES. Addition of
heat-killed cells (OD600 0.2), equilibration for 2 to 5 min
followed by the removal of cells by filtration show a steady
disappearance of the peak. The uranyl-citrate peak decreases by
17% after 2 min of equilibration with cells and by 22% after 5
min. Moreover, the addition of a higher cell concentration
(OD600 0.5) results in a more dramatic disappearance (59%) of
the uranyl-citrate peak. The characteristic uranyl peak at 420
nm (Fig. 2) does not appear, suggesting that uranyl is not
released into solution. These data show that, under these con-
ditions, the uranyl-citrate complex initially present dissociates
in the presence of metabolically inactive cells and that the
uranyl released from the complex binds to cells. Thus, under
these conditions, cells outcompete citrate for uranyl and strip
off uranyl from the preformed uranyl-citrate complex. These
results suggest that P. fluorescens cells act as a ligand for
uranyl and may participate in the speciation of the cation.
We have conducted an empirical study of the kinetics of
formation of the uranyl-citrate complexes to confirm their
formation within the equilibration time. The results are shown
in Figure 3. The spectrum obtained immediately upon mixing
of uranyl and citrate is identical to that obtained after 1 week of
equilibration under sterile conditions. The kinetics of formation
of the complex appear to be extremely rapid and the complex-
(es) can be assumed to form instantaneously.
Fig. 1. Percent of initial uranyl remaining in solution after addition
of P. fluorescens cells (added at t  0 and with an OD600 0.1) in BS1
and in the presence of 1 mol/L citrate. Initial uranyl is 1, 3 or 5
mol/L at pH 6.0. Controls with heat-killed cells or no cells are shown. Fig. 2. Absorbance of the uranyl-citrate complex in BS1 before and
after addition of P. fluorescens cells. The spectra 2 and 5 min after the
addition of heat-killed cells (OD600 0.2) are shown. Also, the spectrum
2 min after addition of cells (OD600 0.5) and the spectrum with no
citrate are shown. [uranyl]T  [citrate]T  100 mol/L, pH 6.0.
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3.2. Inhibitory Effect of Uranyl
The ability of P. fluorescens to degrade citrate under non-
growth conditions and in the presence of low, environmentally
relevant, concentrations of uranyl was evaluated. P. fluorescens
degrades citrate (1 mol/L) at an initial rate of 0.12 mol · h1
· mg protein1 under non-growth conditions (Fig. 4) as indi-
cated by the rapid drop in the solution concentration of 14C-
citrate. In the presence of equimolar uranyl, the initial rate of
citrate degradation is similar at 0.1 mol · h1 · mg protein1
(Fig. 4). At increasing uranyl concentrations, citrate degrada-
tion is slower (initial degradation rate of 0.035 and 0.025 mol
· h1 · mg protein1 for 3 and 5 mol/L uranyl respectively)
and ceases at a higher remaining citrate concentration (Fig. 4).
In the presence of 3 mol/L uranyl, 45% of citrate is degraded
after 25 h whereas only 18% is consumed in the presence of 5
mol/L uranyl in the same time interval (Fig. 4). In the pres-
ence of heat-killed cells, citrate is not degraded and remains in
solution (Fig. 4).
There are two plausible explanations for the observed de-
crease in the rate of citrate degradation with increasing uranyl
concentration: (1) at higher (3 or 5 mol/L) uranyl concentra-
tions, the concentration of the bioavailable citrate species (as-
suming that uranyl-citrate complex itself is not bioavailable) is
significantly lower than the half-velocity coefficient (Km) for
citrate degradation and thus the degradation rate of citrate is
minimal; or (2) uranyl inhibits the metabolism of P. fluorescens
and increasing uranyl concentrations shut down citrate metab-
olism with increasing efficiency. The former (1) is unlikely
because there is at least 0.5 mol/L citrate (50% of the total
citrate) that is not complexed to uranyl in the presence of 5
mol/L uranyl, yet only 18% is degraded (Fig. 4). At least 0.5
mol/L citrate is not complexed to uranyl because, according
to Figure 1, only 0.5 mol/L uranyl remains in solution in the
presence of cells. The maximum concentration of complexed
citrate equals the total concentration of uranyl: 0.5 mol/L
citrate.
Glucose was used as a substrate to unambiguously decon-
volute a potential inhibitory effect from the effect of a low
substrate concentration. Glucose is not known to complex
uranyl and therefore uranyl is only present as the free ion, the
hydroxy and the carbonato complexes (Table 1) and the amount
of bioavailable glucose can be measured directly.
The effect of uranyl on glucose degradation by P. fluorescens
is similar to that on citrate degradation (Fig. 5). In the presence
of 1 mol/L uranyl, the initial rate of glucose degradation is
slightly lower than in the absence of uranyl (0.16 vs. 0.11 mol
glucose · h1 · mg protein1). At higher uranyl concentrations
(3 and 5 mol/L), glucose degradation does not exceed 15%
after 30 h (and the initial rate is 0.04 mol glucose · h1 · mg
protein1). We deduce that, under the present conditions, mi-
cromolar uranyl has an inhibitory effect on the metabolism of
glucose and citrate by P. fluorescens. To confirm that deduc-
tion, we conducted viability tests for cells exposed to uranyl
and citrate or uranyl and glucose.
Figure 6 shows the colony forming units (CFU) counted on
Fig. 3. UV-VIS spectra of uranyl and citrate (5 and 12.5 mmol/L
respectively at pH 5.2) upon mixing, after 1 h, 24 h and 1 week are
identical. The spectrum of 5 mmol/L uranyl at pH 4.16 is also shown.
Fig. 4. Citrate (1 mol/L) degradation in BS1 by P. fluorescens
(OD600 0.1) in the absence of uranyl and in the presence of 1, 3 or 5
mol/L uranyl at pH 6.0. The control with heat-killed cells is included.
Fig. 5. Degradation of glucose (10 mol/L) by P. fluorescens (OD600
0.1) in BS1 in the absence of uranyl, in the presence of 1, 3 5 mol/L
uranyl at pH 6.0.
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agar plates after P. fluorescens cells were exposed to uranyl
(various concentrations) and 1 mol/L citrate (panel A) or 10
mol/L glucose (panel B) for varying durations. Total cell
counts of cells not exposed to uranyl do not change signifi-
cantly, whereas CFU of cells exposed to uranyl decrease over
the duration of exposure. In particular, cells exposed to 3, 5 or
10 mol/L uranyl show a precipitous decrease in CFU. Cells
exposed to uranyl and citrate for 3 h and plated on a solid agar
medium devoid of uranyl display a  70-fold decrease in
viable cell counts (Fig. 6A). A similar behavior is observed for
cells exposed to uranyl and glucose (Fig. 6B). These results
confirm the above suggestion that uranyl inhibits both citrate
and glucose metabolism.
The inhibition of P. fluorescens metabolism by uranyl can be
reversed by adding a strong U(VI) complexing agent to the
solution. Figure 7 shows the degradation of citrate (1) for cells
never exposed to uranyl, (2) for cells exposed to uranyl and
washed in 0.1 mol/L potassium bicarbonate and (3) for cells in
the presence of uranyl. After washing the cells with a bicar-
bonate solution, a significant recovery in activity ensues (Fig.
7). Cells were lost during the wash procedure, thus the ob-
served rate of citrate degradation after washing (seen on Fig. 7)
is an underestimate relative to the rate normalized to cell mass.
More accurately, the calculated rate of citrate degradation is
0.04 mol · h1 · mg protein1 for unwashed cells as com-
pared to 0.18 mol · h1 · mg protein1 for washed cells. The
rate of citrate degradation for washed cells remains well below
the rate for cells never exposed to uranyl0.6 mol · h1 · mg
protein1.
Cell washing with a bicarbonate solution correlates directly
with the recovery of uranyl in solution. Figure 8 shows the
amount of uranyl in solution after washing. Approximately
90% of the uranyl associated with cells is recovered by washingFig. 6. Colony forming units (CFU) of P. fluorescens (1.4  1011
cells · L1) exposed to 1 mol/L citrate (panel A) or 10 mol/L
glucose (panel B) and various concentrations of uranyl for the number
of hours corresponding to the x-axis and diluted by 104 in BS1 before
plating on tryptone glucose plates.
Fig. 7. Citrate (10 mol/L) degradation in BS1 by P. fluorescens
(OD600 0.3) cells never exposed to uranyl, in the presence of 20 mol/L
uranyl, exposed to 20 mol/L uranyl for 4 h and washed with 0.1 mol/L
KHCO3.
Fig. 8. Distribution of uranyl (20 mol/L) in BS1 solution containing
10mol/L citrate in the presence of unwashed cells (filled) and washed
cells (blank). Column 1: initial uranyl concentration in solution before
cell addition. Column 2: uranyl concentration in solution after cell
addition. Column 3: uranyl in bicarbonate wash solution after the wash.
Column 4: uranyl associated with the cells. Column 5: mass balance of
uranyl is equal to the sum of uranyl left in solution after cell addition
(column 2), uranyl recovered by washing (column 3) and uranyl asso-
ciated with cells (column 4).
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with 0.1 mol/L bicarbonate. Carbonate is a strong complexing
agent for uranyl and strips uranyl from the cell surface by
forming uranyl-carbonate complexes in solution. The amount
of uranyl associated with washed cells is negligible (Fig. 8).
The metabolic inhibition of P. fluorescens by uranyl appears to
be associated with the passive binding of uranyl to cells. The
binding is passive (i.e., does not require the use of energy by
cells) because heat-killed cells scavenge uranyl as effectively
as live cells (Fig. 1).
The recovery of metabolic activity after treatment with bi-
carbonate is consistent with the results from the viability ex-
periments (Fig. 6). Cells exposed to uranyl (3, 5 or 10 mol/L)
and plated on agar grew poorly (Fig. 6) because the dilution in
BS1 buffer (0.1 mol/L KCl and 10 mmol/L MES) carried out
before plating did not remobilize the uranyl into solution.
Uranyl was still associated with cells when they were plated on
agar and consequently, the cells were unable to metabolize the
tryptone glucose substrate and could not grow.
3.3. Localization of Uranyl Within Cells
Treatment with bicarbonate recovers 85 to 95% of the initial
uranyl (Fig. 8). This suggests that (1) most of the uranyl is
associated with the outside of the cell and that (2) the uranyl-
cell interaction is a relatively labile “complex.” To confirm the
former suggestion, we conducted cell fractionation and thin-
section TEM (Transmission Electron Microscopy) analyses of
cells exposed to uranyl. Cell fractionation demonstrated the
presence of uranyl in the membrane fraction (Fig. 9). Approx-
imately 98% of uranyl was associated with the membrane
fraction (Fig. 9).
Thin-section TEM micrographs (Figs. 10 and 11) further
confirm the localization of uranyl. Uranyl (the only electron-
dense atom present in the sample) is clustered in the mem-
brane(s) (Fig. 11). Uranyl is associated with both the outer and
the cytoplasmic membranes and also deposits along the
periplasm separating the two membranes (Fig. 10). Finally,
Energy Dispersive X-ray (EDX) analysis confirms that the
deposit is indeed U and shows no significant contribution from
potential contaminants such as Fe (Fig. 12).
Fig. 9. Distribution of uranyl in cellular fractions after French
Pressing and slow centrifugation (large pie) and after ultra-centrifuga-
tion of the supernatant from the slow centrifugation (small pie).
Unlysed cells in the pellet after slow centrifugation were accounted for
and their contribution to the slow centrifugation pellet subtracted.
Fig. 10. Transmission electron micrograph of P. fluorescens cells
exposed to 100 mol/L uranyl. The samples have not been stained.
High electron density corresponds to the presence of uranyl. The
membranes (both outer and inner) are significantly darker than the
cytoplasm which indicates that uranyl accumulates in the membranes
and periplasm.
Fig. 11. Transmission electron micrograph of P. fluorescens cells
exposed to 100 mol/L uranyl. The samples have not been stained.
High electron density corresponds to the presence of uranyl. The
membranes (both outer and inner) are significantly darker than the
cytoplasm which indicates that uranyl accumulates in the membranes
and periplasm.
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4. DISCUSSION
This study shows that P. fluorescens, a common subsurface
denitrifier, can serve as a ligand for uranyl. Under the condi-
tions investigated (Fig. 2), cells rapidly scavenge solution ura-
nyl and even outcompete citrate for uranyl, leading to the
dissociation of preformed uranyl-citrate complex(es). Metabol-
ically inactive cells also cause the dissociation of uranyl-citrate
complex(es) and scavenge uranyl. Thus, the dissociation of
uranyl-citrate complexes can be attributed to the depletion of
uncomplexed uranyl by binding to the cell envelope, rather than
to the depletion of uncomplexed citrate by biodegradation.
The ability of P. fluorescens to outcompete citrate for uranyl
under the conditions studied is probably due to the low con-
centration of citrate present and the absence of other uranyl-
binding ligands (principally carbonate). As with all ligands, the
amount of uranyl complexed by cells will vary according to the
relative concentration of uranyl, cells, other ligands and pH.
One situation in which cells may complex a significant amount
of uranyl is during the bioremediation of a low-carbonate site,
where high cell concentrations are expected due to the bioaug-
mentation or biostimulation strategies.
Electron micrographs (Figs. 10 and 11) show the association
of uranyl with both the outer and the cytoplasmic membranes
as well as with the periplasm. A study of uranyl biosorption on
another strain of P. fluorescens shows the association of uranyl
with the cell envelope with the exception of 10% of the cells
that accumulate uranyl intracellularly (Krueger et al., 1993). In
that study, uranyl precipitates as platy crystals aligned in the
periplasm so that their flat surfaces associate with the periplasm
side of the outer and cytoplasmic membranes. It may be that
those crystals are a uranyl phosphate phase formed during a cell
wash with a phosphate buffer.
The present study scrupulously excluded phosphate. Spec-
troscopic and isotherm data both show no evidence of uranyl
precipitation onto the cell surface (data not shown). Moreover,
a rapid wash of uranyl-laden cells with bicarbonate released
90% of uranyl suggesting the presence of a labile uranyl-cell
“complex” rather than a precipitate. Thus, we characterize the
association of uranyl with cells as complexation. A similar
complexation was described by Haas et al. (2001) for the
association of uranyl with another gram-negative bacterium
Shewanella putrefaciens.
The precise nature of the uranyl-cell complex is unknown.
Researchers have suggested the importance of carboxyl and
phosphato functional groups in the biosorption of uranyl by
both gram-positive (Fowle et al., 2000; Kelly et al., 2001) and
gram-negative bacteria (Haas et al., 2001; Kelly et al., 2002).
We are currently investigating the molecular details of uranyl
binding to the surface of P. fluorescens.
Under our experimental conditions, a large fraction of uranyl
present is biosorbed and, consequently, a large fraction of
citrate is uncomplexed (Fig. 1). Therefore, citrate is expected to
be readily degraded by cells in the presence of uranyl because
citrate is present to a large extent as either free citrate or
Kcit2, both biodegradable species. However, we observe little
citrate degradation in the presence of some concentrations of
uranyl (5 mol/L). Similarly, there is little glucose degrada-
tion in the presence of 3 mol/L uranyl or higher. These results
reveal the inhibitory effect of uranyl on cell metabolism of both
citrate and glucose even at micromolar concentrations.
The inhibition appears to be associated with the binding of
uranyl to the cell envelope. A cell wash with bicarbonate
recovers 90% of uranyl and leads to a recovery (30%) in
metabolic activity of cells. The link between uranyl binding to
the cell surface and the inhibitory effect of uranyl is important
because it suggests that biosorption inhibits metabolism. The
ease of reversibility of the inhibition by washing with a com-
plexing agent strengthens the argument that the inhibitory
effect of uranyl is not associated with intracellular intake of
uranyl but rather with binding to the cell surface. We hypoth-
esize that the binding of U may alter the conformation of
membrane proteins crucial for the metabolism of citrate and
glucose or that uranyl biosorption reduces membrane fluidity
and permeability, thus limiting citrate and glucose uptake. The
cells recover only 30% of their activity after washing with
bicarbonate even as 90% of uranyl is in solution, suggesting a
hysteresis effect in the recovery from uranyl biosorption.
Several studies have described the toxic effect of uranyl on
bacterial metabolism. An early study (Barron et al., 1948)
documented the toxic effect of uranyl on yeast and bacteria,
including Pseudomonas aeruginosa. Tuovinen and Kelly
(1974a, 1974b) also recorded the toxic effect of uranyl on the
iron oxidizer Thiobacillus ferrooxidans at acidic pH. They
found that the presence of a chelator such as EDTA or a high
concentration of competing cations reduced the inhibitory ef-
fect of uranyl on T. ferrooxidans.
Huang et al. (1998) studied the degradation of citrate in the
presence of uranyl by a growing mixed culture. At pH 6, they
found that 73% of citrate was degraded within 100 h when
present in threefold excess but no further reduction took place
in the following 140 h. At that pH, uranyl was sorbed to cells
extensively (50%). At higher citrate:uranyl ratios (8:1), com-
plete citrate degradation was observed within 130 h at pH 6 but
less uranyl was associated with cells. For pHs at which solution
carbonate limits U sorption to cells (e.g., pH 8, 9), citrate
degradation was unhindered and proceeded to 100% within
10 h even at low citrate:uranyl ratios. The authors attributed the
difference in citrate degradation at pH 6 and 8 to changes in
uranyl speciation (carbonate vs. citrate complexes). Nonethe-
Fig. 12. Energy dispersive X-ray spectrum if the membrane of a cell
exposed to uranyl. X-rays from the uranium L and M shells are clearly
detectable, while no X-rays from Fe appear. The Ni signal comes from
the grid.
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less, there appears to be a correlation between incomplete
citrate degradation and sorption of uranyl onto cells in their
data. The study (Huang et al., 1998) was conducted under
growth conditions, with a mixed bacterial community and with
considerably higher uranyl and citrate concentrations ([uranyl]
 0.42 mmol/L and [citrate]  0.55–3.5 mmol/L). Despite the
major differences with conditions in our study, the effect of
biosorbed uranyl on citrate biodegradation was also observed.
Other studies show different results. Joshi-Tope and Francis
(1995) and Francis et al. (1992) found that P. fluorescens was
unable to degrade citrate in the presence of equimolar uranyl.
Cell free extract of the cells readily degraded 100% of citrate in
the presence of equimolar uranyl. The authors suggested that
the uranyl-citrate complexes had limited lability, rendering
citrate non-bioavailable. Unfortunately, no uranyl measure-
ments were made and thus was not possible to assess the
fraction of uranyl sorbed to cells in those experiments.
The toxic species responsible for binding to cells and inhib-
iting metabolism was not identified in this study. However, due
to the chemical simplicity of the system studied, only four
species can be considered as possible inhibitors: UO22,
UO2Cl, UO2OH and (UO2)2(OH)22. Only two hydroxide
species are considered because, the inhibitory species is likely
to be a cation due to its binding to the negatively charged
surface of cells. Banaszak et al. (1999) concluded that a uranyl-
citrate complex was the toxic species. The design of our ex-
periments does not allow a definitive conclusion on the toxicity
of the uranyl-citrate complex. However, it is clear that there is
at least one additional inhibitory species as inhibition was also
observed in the absence of citrate.
5. CONCLUSIONS
This study shows that, under the conditions studied, the
cellular envelope of P. fluorescens serves as a ligand for uranyl.
Additionally, the binding of uranyl to the cell envelope results
in the inhibition of cell metabolism. The inhibition is reversible
by desorbing uranyl.
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